{
    "2021-09-17": [
        [
            {
                "time": "",
                "original_text": "凯莱英(002821.SZ)副总经理肖毅减持2.26万股 减持数量过半 减持股份",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "副总经理",
                        "肖毅",
                        "减持",
                        "2.26万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：副总经理肖毅减持约2.26万股 减持股份",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "副总经理",
                        "肖毅",
                        "减持",
                        "2.26万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "ADC药物：偶联时代 创新致远",
                "features": {
                    "keywords": [
                        "ADC药物",
                        "偶联",
                        "创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗服务行业周报：创新药融资前景乐观 外包服务将持续受益",
                "features": {
                    "keywords": [
                        "医疗服务",
                        "创新药",
                        "融资",
                        "外包服务",
                        "持续受益"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}